Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kevin Joseph
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Cancers
Cancer Research
Oncology
Related publications
Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27
Acta Pharmacologica Sinica
Medicine
Pharmacology
Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition
Oncology Reports
Medicine
Cancer Research
Oncology
RNA Interference Targeting Aurora-A Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy
Oncology Letters
Cancer Research
Oncology
Casein Kinase 2 Inhibition Sensitizes Medulloblastoma to Temozolomide
Oncogene
Cancer Research
Genetics
Molecular Biology
Regulation of the Oxidative Balance With Coenzyme Q10 Sensitizes Human Glioblastoma Cells to Radiation and Temozolomide
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway
Anatomical Record
Evolution
Ecology
Systematics
Anatomy
Histology
Behavior
Biotechnology
Epigenetic Preconditioning With Decitabine Sensitizes Glioblastoma to Temozolomide via Induction of MLH1
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Bone Morphogenetic Protein 7 Sensitizes O6-Methylguanine Methyltransferase Expressing-Glioblastoma Stem Cells to Clinically Relevant Dose of Temozolomide
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
ACS Applied Materials & Interfaces
Medicine
Materials Science
Nanotechnology
Nanoscience
